ImmunoPrecise Antibodies Ltd (IPA)
1.18
+0.06
(+5.36%)
USD |
NASDAQ |
May 17, 16:00
1.19
+0.01
(+0.85%)
After-Hours: 20:00
ImmunoPrecise Antibodies Price to Book Value: 0.8354 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.8354 |
| May 16, 2024 | 0.7929 |
| May 15, 2024 | 0.813 |
| May 14, 2024 | 0.8496 |
| May 13, 2024 | 0.892 |
| May 10, 2024 | 0.9133 |
| May 09, 2024 | 0.892 |
| May 08, 2024 | 0.9062 |
| May 07, 2024 | 0.9062 |
| May 06, 2024 | 0.9274 |
| May 03, 2024 | 0.9062 |
| May 02, 2024 | 0.892 |
| May 01, 2024 | 0.885 |
| April 30, 2024 | 0.9062 |
| April 29, 2024 | 0.9699 |
| April 26, 2024 | 0.9345 |
| April 25, 2024 | 0.8453 |
| April 24, 2024 | 0.8637 |
| April 23, 2024 | 0.8637 |
| April 22, 2024 | 0.885 |
| April 19, 2024 | 0.892 |
| April 18, 2024 | 0.8779 |
| April 17, 2024 | 0.8991 |
| April 16, 2024 | 0.9133 |
| April 15, 2024 | 0.8779 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.9628 |
| April 11, 2024 | 0.9699 |
| April 10, 2024 | 0.9841 |
| April 09, 2024 | 0.977 |
| April 08, 2024 | 1.005 |
| April 05, 2024 | 1.020 |
| April 04, 2024 | 1.027 |
| April 03, 2024 | 1.027 |
| April 02, 2024 | 1.041 |
| April 01, 2024 | 1.083 |
| March 28, 2024 | 1.076 |
| March 27, 2024 | 1.112 |
| March 26, 2024 | 1.076 |
| March 25, 2024 | 1.076 |
| March 22, 2024 | 1.112 |
| March 21, 2024 | 0.9912 |
| March 20, 2024 | 0.9982 |
| March 19, 2024 | 1.027 |
| March 18, 2024 | 0.9912 |
| March 15, 2024 | 1.020 |
| March 14, 2024 | 1.126 |
| March 13, 2024 | 1.154 |
| March 12, 2024 | 1.161 |
| March 11, 2024 | 1.239 |
| March 08, 2024 | 1.303 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.703
Minimum
Oct 20 2023
13.47
Maximum
Dec 29 2020
3.377
Average
2.642
Median
Dec 28 2021
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.3909 |
| Aurinia Pharmaceuticals Inc | 2.180 |
| Edesa Biotech Inc | 3.384 |
| Lexaria Bioscience Corp | 6.225 |
| Xenon Pharmaceuticals Inc | 3.384 |
Price to Book Value Related Metrics
| PS Ratio | 1.698 |
| Price | 1.18 |
| Earnings Yield | -35.15% |
| Market Cap | 31.05M |